Investing.com - Vigil Neuroscience (NASDAQ: VIGL) reported fourth quarter EPS of $-0.48, $0.10 better than the analyst estimate of $-0.58. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Vigil Neuroscience's stock price closed at $10.20. It is up 0.79% in the last 3 months and up 23.62% in the last 12 months.
Vigil Neuroscience saw positive EPS revisions and negative EPS revisions in the last 90 days. See Vigil Neuroscience's stock price’s past reactions to earnings here.
According to InvestingPro, Vigil Neuroscience's Financial Health score is "weak performance".
Check out Vigil Neuroscience's recent earnings performance, and Vigil Neuroscience's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar